|
|
The Body Covers: The XV International AIDS Conference
Complete Index
Special Features
Antiretroviral Therapy: Treatment-Experienced Patients
- Enfuvirtide Benefits Persist for at Least 2 Years (Oral MoOrB1058)
Coverage by Calvin J. Cohen, M.D., M.S.
- More Data on Higher-Dose Lopinavir/Ritonavir (Poster TuPeB4555)
Coverage by Paul E. Sax, M.D.
- Five Days On, 2 Days Off: A Pilot Study on Innovative Treatment of HIV Infection (Poster TuPeB4575)
Coverage by Gerald Pierone Jr., M.D.
- Tenofovir and Abacavir Do Not Interact in Patients on Triple-Nucleoside Regimens (Poster TuPeB4627)
Coverage by Calvin J. Cohen, M.D., M.S.
- Failure of Tenofovir/Abacavir/Lamivudine Combination Still Unexplained (Poster TuPeB4629)
Coverage by Mark Holodniy, M.D., F.A.C.P., C.I.C.
Antiretroviral Therapy: Treatment-Naive Patients
- Fosamprenavir Update (Oral MoOrB1055, Poster TuPeB4504, Poster TuPeB4506, Poster TuPeB4507)
Coverage by Benjamin Young, M.D., Ph.D.
- Most Common Regimens Used in San Francisco Yield Equal Chances of Survival (Oral MoOrC1082)
Coverage by Frank S. Rhame, M.D.
- Update on Long-Term Follow-Up Studies on Tenofovir (Oral MoOrB1083, Poster TuPeB4538, Poster WePeB5757, Poster WePeB5917)
Coverage by Benjamin Young, M.D., Ph.D.
- Data on HIV Disease Prognosis 5 Years After Initiating HAART (Oral TuOrC1157)
Coverage by Thanes J. Vanig, M.D.
- Confort Study Supports Switch From Protease Inhibitor to Nevirapine (Oral WeOrB1287)
Coverage by Frank S. Rhame, M.D.
- Zidovudine/Lamivudine/Abacavir May Be Effective Alone for Induction Maintenance (Oral LbOrB14)
Coverage by Frank S. Rhame, M.D.
- Negative HIV Antibody Test Results Among People Treated During Acute/Early Infection (Poster MoPeB3107)
Coverage by David A. Wohl, M.D.
- Patients Beginning HAART With a Low CD4+ Cell Count Respond Well (Poster MoPeB3356)
Coverage by Thanes J. Vanig, M.D.
- HIV Infection and Antiretroviral Therapy in Patients Over 50 (Poster MoPeB3366)
Coverage by Thanes J. Vanig, M.D.
- Lamivudine/Abacavir Is an Effective Nucleoside Backbone in Combinations Other Than With Tenofovir (Poster TuPeB4502)
Coverage by Frank S. Rhame, M.D.
- Update on the Safety and Efficacy of Abacavir (Poster TuPeB4521, Poster WePeB5698, Poster WePeB5868)
Coverage by Benjamin Young, M.D., Ph.D.
- A Head-to-Head Comparison of Initial HIV Treatment With PI-, NNRTI- or NRTI-Based Regimens (Poster TuPeB4544, Poster WePeB5944)
Coverage by David A. Wohl, M.D.
- Drug Switching Can Resensitize Patients With Multidrug-Resistant HIV-1 (Poster TuPeB4556)
Coverage by Mark Holodniy, M.D., F.A.C.P., C.I.C.
- Treatment of HIV Infection With Prednisolone (Poster TuPeB4582)
Coverage by Gerald Pierone Jr., M.D.
Complications of HIV/HAART
- Metabolic Complications of HIV and Its Therapies (Oral MoOrB1060, Oral MoOrB1083, Poster TuPeB4577, Poster TuPeB4595, Poster WePeB5874, Poster WePeB5925, Poster WePeB5964)
Coverage by David A. Wohl, M.D.
- Are Protease Inhibitors More Likely to Cause Atherosclerosis Than NNRTIs? (Oral ThOrB1355)
Coverage by Thanes J. Vanig, M.D.
- HAART Reduces Incidence and Improves Long-Term Prognosis of Non-Hodgkin's Lymphoma (Oral ThOrB1403)
Coverage by Frank S. Rhame, M.D.
- HDL Benefit Is Maintained With Extension of Nevirapine and Efavirenz Treatment in 2NN Study (Poster WePpB2065)
Coverage by Gerald Pierone Jr., M.D.
- Anal Cancer Still a Risk to HIV-Infected Men Who Have Receptive Anal Intercourse (Poster MoPeB3251)
Coverage by Frank S. Rhame, M.D.
- Non-Hodgkin's Lymphoma Rates Lower in HAART-Treated Patients (Poster MoPeB3257)
Coverage by Frank S. Rhame, M.D.
- Aging HIV-Infected Population at Risk for Malignancies Despite HAART (Poster MoPeB3264)
Coverage by Frank S. Rhame, M.D.
- Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (Poster MoPeB3285)
Coverage by Paul E. Sax, M.D.
- Both Tenofovir and Stavudine Well Tolerated in HCV-Coinfected Patients (Poster MoPeB3307)
Coverage by Paul E. Sax, M.D.
- HBV Infection: Two Drugs Are Better Than One (Poster MoPeB3308)
Coverage by Paul E. Sax, M.D.
- A HAART Regimen With Lower Metabolic Effect (Poster WePeB5865)
Coverage by Margaret Hoffman-Terry, M.D., F.A.C.P.
- Substituting With Tenofovir Decreases the Adverse Effects Seen With Other NRTIs (Poster WePeB5880)
Coverage by Calvin J. Cohen, M.D., M.S. - Hypertriglyceridemic Patients on HAART Have Increased Risk of Cardiovascular Disease (Poster WePeB5902)
Coverage by Thanes J. Vanig, M.D.
- Bone Cement Injections Show Success as Facial Wasting Treatment (July 16, 2004)
Coverage by Reuters
HIV Drug Resistance
HIV Drugs in Development
HIV Prevention
- HIV Prevention Programs for Teens Must Deal With Sexuality, Youth Speakers Say (July 15, 2004)
Coverage by Associated Press
- Cambodian Sex Workers Protest Study on Use of Tenofovir to Prevent HIV (July 15, 2004)
Coverage by kaisernetwork.org
- HIV Prevention Programs Must Target Displaced Populations, Experts Say (July 15, 2004)
Coverage by kaisernetwork.org
- Voucher Program for Injection Drug Users in Asia Reduces HIV Incidence (July 15, 2004)
Coverage by kaisernetwork.org
- Discrimination, Gender Inequality Challenge HIV Prevention Efforts in South Asia (July 15, 2004)
Coverage by kaisernetwork.org
- Microbicide Trials to Be Aimed at Women Due to Growing HIV/AIDS Impact on Female Population (July 14, 2004)
Coverage by kaisernetwork.org
- Emphasis on Ethnic Pride, Communication Reduces HIV Risk Behavior Among African-American Girls (July 13, 2004)
Coverage by kaisernetwork.org
- Ugandan President Stirs Controversy for Downplaying Use of Condoms to Prevent HIV (July 12, 2004)
Coverage by Associated Press
- HIV Vaccine Research Funding Is Far Below Needed Level, Vaccine Initiative's Report Says (July 12, 2004)
Coverage by kaisernetwork.org
HIV Transmission & Pathogenesis
Treatment Access and Policy
- Governments That Bar Injection Drug Users From Treatment Fuel Spread of HIV, WHO Says (July 19, 2004)
Coverage by kaisernetwork.org
- U.K. Rejects U.S. Policies on HIV Prevention, Generic Antiretrovirals (July 16, 2004)
Coverage by kaisernetwork.org
- Researchers Unveil Portable, Battery-Powered CD4 Monitoring Device (July 15, 2004)
Coverage by Reuters
- Antiretroviral Doses, Treatment Tools Ignore Needs of Children, Medical Group Says (July 15, 2004)
Coverage by Reuters
- Generic Fixed-Dose Combination Drugs Succeed in First Large-Scale Study (July 15, 2004)
Coverage by kaisernetwork.org
- Widespread Nevirapine Resistance May Threaten Asia Due to Poor Adherence, Treatment Monitoring (July 15, 2004)
Coverage by kaisernetwork.org
- Interview With Ambassador Randall Tobias (July 14, 2004)
Coverage by kaisernetwork.org
- Médecins Sans Frontières Presents Data Showing Antiretroviral Therapy Can Improve Survival in Developing Countries (July 14, 2004)
Coverage by kaisernetwork.org
- U.S. Global AIDS Coordinator Tobias Addresses XV International AIDS Conference; Speech Interrupted by Protesters (July 14, 2004)
Coverage by kaisernetwork.org
- Disagreement, Poor Coordination Among Donors Hinder Global AIDS Fight, Experts Say (July 13, 2004)
Coverage by kaisernetwork.org
- Half of Global Fund Grant Recipients Performing Well, Report Says (July 13, 2004)
Coverage by kaisernetwork.org
- Protesters, Targeting Drug Companies, Disrupt More Events at AIDS 2004 (July 13, 2004)
Coverage by kaisernetwork.org
- Funding the Response to HIV/AIDS: Why Are Donors Not Working Together? (July 12, 2004)
Available in PDF, RealPlayer video and Windows Media video
Coverage by kaisernetwork.org
- HIV Treatment Access Protesters Make Their Presence Felt at AIDS 2004 (July 12, 2004)
Coverage by kaisernetwork.org
- U.S. Official Defends Global AIDS Initiative Amidst Protests at AIDS 2004 (July 12, 2004)
Coverage by kaisernetwork.org
- HIV Treatment Programs in India, South Africa, Thailand Discussed at AIDS 2004 (July 12, 2004)
Coverage by kaisernetwork.org
- AIDS 2004 Satellite Meeting Assesses Slow Advance of Global Treatment Access (July 12, 2004)
Coverage by kaisernetwork.org
- Thai Prime Minister Pledges HIV Treatment for All Citizens, but Advocates Are Skeptical (July 12, 2004)
Coverage by kaisernetwork.org
Women & Pregnancy
|
|
